Dymista: payments to doctors
Payments that named Dymista as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $48K
- Providers
- 158
- Transactions
- 209
- Average per transaction
- $231
The per-transaction average — $231 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 158 providers the average total is $305, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Mylan Pharmaceuticals Inc. | $28,192 | 58.5% |
| Mylan Inc. | $11,558 | 24.0% |
| Mylan Specialty L.p. | $8,398 | 17.4% |
| Mylan LLC | $77 | 0.2% |